Georgia Senate Bill SR506

Georgia 2023-2024 Regular Session

• Introduced: 1/26/24
• Enrolled: 1/29/24
• Passed: 1/29/24

Caption

Multiple Sclerosis Awareness Day; recognize January 29, 2024

Impact

The resolution works to foster greater public recognition of multiple sclerosis and the challenges faced by those diagnosed with it. By declaring a specific day dedicated to awareness, the resolution seeks to generate discussion around the disease, encouraging communities to participate in awareness activities and fundraising for MS research. The objectives of SR506 align with the goals of the National Multiple Sclerosis Society, which advocates for research into the disease while supporting affected individuals. This increased visibility can lead to greater community support and engagement in ongoing MS research efforts.

Summary

Senate Resolution 506 aims to designate January 29, 2024, as Multiple Sclerosis Awareness Day in the state of Georgia. This resolution seeks to raise awareness regarding multiple sclerosis (MS), a neurological disease that affects around 1 million people in the United States, primarily those aged between 20 and 50. By officially recognizing this day, the resolution aims to encourage citizens to educate themselves about MS and to support individuals living with the condition and their families. The resolution highlights the importance of public awareness in advancing research and better treatment options for MS.

Contention

While Senate Resolution 506 is largely symbolic, as it does not create new laws or regulations, it holds the potential to spark conversations around the importance of investing in healthcare research and support for individuals with neurological diseases. One notable point of contention may arise around whether or not state resources and funding should be allocated towards MS awareness initiatives and research, which could be debated among lawmakers seeking to address a variety of health issues. Ultimately, the resolution emphasizes the need for united efforts to combat MS and improve the lives of those affected by the disease.